Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. <i>Lactobacillus paracasei</i> GMNL-32, <i>Lactobacillus reuteri</i> GMNL-89 and <i>L. reuteri</i> GMNL-263 ameliorate hepatic injuries in lupus-prone mice
 
  • Details
Options

<i>Lactobacillus paracasei</i> GMNL-32, <i>Lactobacillus reuteri</i> GMNL-89 and <i>L. reuteri</i> GMNL-263 ameliorate hepatic injuries in lupus-prone mice

Journal
British Journal of Nutrition
Journal Volume
117
Journal Issue
8
Start Page
1066-1074
ISSN
0007-1145
1475-2662
Date Issued
2017-04-28
Author(s)
Tsai-Ching Hsu  
Chih-Yang Huang
Chung-Hsien Liu
Kuo-Ching Hsu
Yi-Hsing Chen
Bor-Show Tzang  
DOI
10.1017/S0007114517001039
URI
https://scholars.csmu.edu.tw/handle/123456789/3542
Abstract
<jats:title>Abstract</jats:title><jats:p>Probiotics are known to regulate host immunity by interacting with systemic and mucosal immune cells as well as intestinal epithelial cells. Supplementation with certain probiotics has been reported to be effective against various disorders, including immune-related diseases. However, little is known about the effectiveness of <jats:italic>Lactobacillus paracasei</jats:italic> GMNL-32 (GMNL-32), <jats:italic>Lactobacillus reuteri</jats:italic> GMNL-89 (GMNL-89) and <jats:italic>L</jats:italic>. <jats:italic>reuteri</jats:italic> GMNL-263 (GMNL-263) in the management of autoimmune diseases, especially systemic lupus erythematosus (SLE). NZB/W F1 mice, which are a lupus-prone animal model, were orally gavaged with GMNL-32, GMNL-89 or GMNL-263 to investigate the effects of these <jats:italic>Lactobacillus</jats:italic> strains on liver injuries in NZB/W F1 mice. The results thus obtained reveal that supplementary GMNL-32, GMNL-89 or GMNL-263 in NZB/W F1 mice ameliorates hepatic apoptosis and inflammatory indicators, such as matrix metalloproteinase-9 activity and C-reactive protein and inducible nitric oxide synthase expressions. In addition, supplementation with GMNL-32, GMNL-89 or GMNL-263 in NZB/W F1 mice reduced the expressions of hepatic IL-1<jats:italic>β</jats:italic>, IL-6 and TNF-<jats:italic>α</jats:italic> proteins by suppressing the mitogen-activated protein kinase and NF-<jats:italic>κ</jats:italic>B signalling pathways. These findings, presented here for the first time, reveal that GMNL-32, GMNL-89 and GMNL-263 mitigate hepatic inflammation and apoptosis in lupus-prone mice and may support an alternative remedy for liver disorders in cases of SLE.</jats:p>
Publisher
Cambridge University Press (CUP)
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback